Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.47 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.47 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.47 |
| ▸ | NMT2 | O60551 | 1/20 | 0.47 |
| ▸ | NMT1 | P30419 | 1/20 | 0.47 |
| ▸ | NPY1R | P25929 | 1/20 | 0.47 |
| ▸ | NPY2R | P49146 | 1/20 | 0.47 |
| ▸ | NPY4R | P50391 | 1/20 | 0.47 |
| ▸ | CPB2 | Q96IY4 | 7/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.45 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29618977 | 0.99 | ERAP2 (0.48) | ERAP2ERAP1LNPEPNMT2NMT1 | |
| SCHEMBL29473878 | 0.97 | NMT2 (0.47) | ERAP2ERAP1LNPEPNMT2NMT1 | |
| SCHEMBL30478747 | 0.96 | NMT2 (0.49) | ERAP2ERAP1LNPEPNMT2NMT1 | |
| SCHEMBL29378561 | 0.96 | NMT2 (0.48) | ERAP2ERAP1LNPEPNMT2NMT1 | |
| SCHEMBL29462935 | 0.94 | ERAP2 (0.45) | ERAP2ERAP1LNPEPNMT2NMT1 | |
| SCHEMBL29592591 | 0.94 | NMT1 (0.52) | ERAP2ERAP1LNPEPNMT2NMT1 | |
| SCHEMBL31314472 | 0.93 | FOLH1 (0.47) | ERAP2ERAP1LNPEPNMT2NMT1 | |
| Sinapultide SCHEMBL180504 | 0.92 | NPY4R (0.53) | ERAP2ERAP1LNPEPNPY1RNPY2R | |
| SCHEMBL31343363 | 0.92 | NPY4R (0.53) | ERAP2ERAP1LNPEPNPY1RNPY2R | |
| SCHEMBL31343323 | 0.92 | NPY4R (0.53) | ERAP2ERAP1LNPEPNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |